Track: CME Session
Track: Hybrid Session
Peter Ly, PhD
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Disclosure(s): No financial relationships to disclose
Brian Rini, MD
Vanderbilt-Ingram Cancer Center
Nashville, TN, United States
Disclosure(s): No financial relationships to disclose
Wenxin Xu, MD
Dana-Farber Cancer Institute
Newton, Massachusetts, United States
Disclosure(s): Advisory Board: Exelixis (Ongoing)
Speaker: Brian Rini, MD – Vanderbilt-Ingram Cancer Center
Speaker: Wenxin Xu, MD – Dana-Farber Cancer Institute
Speaker: Peter Ly, PhD – University of Texas Southwestern Medical Center